Keyphrases
Ovarian Cancer
100%
Poor Prognosis
100%
Arginine Deiminase
100%
Citrullination
50%
Immune System
25%
Poor Survival
25%
Immunohistochemistry
25%
Primary Ovarian Cancer
25%
Tumor Cell Proliferation
25%
Tumor Subtype
25%
High Mobility Group Box 1 (HMGB1)
25%
Tumor Cell Survival
25%
Overall Survival
25%
Validation Cohort
25%
Multivariate Model
25%
Comprehensive Dataset
25%
Tissue Microarray
25%
Monoclonal Antibody
25%
Ovarian Tumor
25%
Kaplan-Meier Analysis
25%
Positive Regulator
25%
Immune Surveillance
25%
Citrullinated Proteins
25%
B-cell Lymphoma 2 (Bcl-2)
25%
Prognostic Marker
25%
Independent Prognostic Factor
25%
Autophagy
25%
Therapeutic Target
25%
Biochemistry, Genetics and Molecular Biology
Enzyme
100%
Downregulation
100%
Citrullination
100%
Arginine Deiminase
100%
Monoclonal Antibody
50%
HMGB1
50%
Autophagy
50%
Cell Survival
50%
Tissue Microarray
50%
Immunosurveillance
50%
Tumor Progression
50%
Overall Survival
50%
Immunology and Microbiology
Downregulation
100%
Citrullination
100%
Arginine Deiminase
100%
Monoclonal Antibody
50%
Autophagy
50%
Tumor Cell
50%
Cell Survival
50%
Overall Survival
50%
Cell Growth
50%
Immunosurveillance
50%
Immune System
50%
Medicine and Dentistry
Ovarian Cancer
100%
Downregulation
100%
Arginine Deiminase
100%
Citrullination
40%
Immunohistochemistry
20%
Ovarian Tumor
20%
Neoplasm
20%
Tissue Microarray
20%
Kaplan Meier Method
20%
Tumor Progression
20%
Monoclonal Antibody
20%
Cell Survival
20%
Overall Survival
20%
Immunosurveillance
20%
Prognostic Factor
20%
Autophagy
20%
Sphingolipid Activator Protein 2
20%
Immune System
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Arginine Deiminase
100%
Neoplasm
20%
Sphingolipid Activator Protein 2
20%
Ovary Tumor
20%
Overall Survival
20%
Tumor Growth
20%
Monoclonal Antibody
20%